Simultaneous B and T cell acute lymphoblastic leukemias in zebrafish driven by transgenic MYC: implications for oncogenesis and lymphopoiesis

Autor: Gilseung Park, Rodney R. Miles, Chiara Borga, Clay A. Foster, Rikin K. Shah, Syed Talha Ahmed, Ameera Hasan, Matteo Marchesin, Lance Batchelor, Silvia Bresolin, Jessica Burroughs-Garcia, James L. Regens, John Kimble Frazer, Geertruy te Kronnie, Teresa Scordino
Jazyk: angličtina
Rok vydání: 2019
Předmět:
0301 basic medicine
Cancer Research
Lymphocyte
Cell
Genetically Modified
Biology
medicine.disease_cause
Cell Transformation
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
Article
Animals
Genetically Modified

Neoplasms
Multiple Primary

Proto-Oncogene Proteins c-myc
03 medical and health sciences
0302 clinical medicine
Multiple Primary
Neoplasms
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
medicine
Animals
Humans
Lymphopoiesis
Zebrafish
Regulation of gene expression
Neoplastic
Gene Expression Profiling
Hematology
biology.organism_classification
Pediatric cancer
3. Good health
Gene Expression Regulation
Neoplastic

Gene expression profiling
Cell Transformation
Neoplastic

030104 developmental biology
medicine.anatomical_structure
Oncology
Gene Expression Regulation
030220 oncology & carcinogenesis
Cancer research
Carcinogenesis
Zdroj: Leukemia
Popis: Precursor-B cell acute lymphoblastic leukemia (pre-B ALL) is the most common pediatric cancer, but there are no useful zebrafish pre-B ALL models. We describe the first highly- penetrant zebrafish pre-B ALL, driven by human MYC. Leukemias express B lymphoblast-specific genes and are distinct from T cell ALL (T-ALL)—which these fish also develop. Zebrafish pre-B ALL shares in vivo features and expression profiles with human pre-B ALL, and these profiles differ from zebrafish T-ALL or normal B and T cells. These animals also exhibit aberrant lymphocyte development. As the only robust zebrafish pre-B ALL model and only example where T-ALL also develops, this model can reveal differences between MYC-driven pre-B vs. T-ALL and be exploited to discover novel pre-B ALL therapies.
Databáze: OpenAIRE